(Bloomberg) Theranos Inc. and founder Elizabeth Holmes were accused in a lawsuit of duping investors about the embattled medical-testing firm’s performance and technology to raise about $100 million in funding for the startup. Partner Investments LP sued Theranos in Delaware state court Monday seeking to rescind a stock-purchase agreement in the wake of scandals involving the Palo Alto, California-based company’s blood-testing capabilities. The hedge fund claims Theranos officials lied about the firm’s performance to raise funding.
Theranos Accused of Duping Investor About Tests, Performance
This entry was posted in Syndicated. Bookmark the permalink.
